Heidi M. Haikala

1.2k total citations
15 papers, 309 citations indexed

About

Heidi M. Haikala is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Heidi M. Haikala has authored 15 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Heidi M. Haikala's work include Cancer, Hypoxia, and Metabolism (3 papers), Protein Degradation and Inhibitors (3 papers) and Ubiquitin and proteasome pathways (3 papers). Heidi M. Haikala is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Protein Degradation and Inhibitors (3 papers) and Ubiquitin and proteasome pathways (3 papers). Heidi M. Haikala collaborates with scholars based in Finland, Germany and United States. Heidi M. Haikala's co-authors include Juha Klefström, Pasi A. Jänne, Anni I. Nieminen, Topi A. Tervonen, Johanna I. Partanen, Yan Yan, Martin Eilers, Mikko Turunen, Katrin E. Wiese and Björn von Eyß and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The EMBO Journal.

In The Last Decade

Heidi M. Haikala

14 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heidi M. Haikala Finland	7	212	131	64	39	36	15	309
Cristina Bernadó Morales Spain	9	144 0.7×	163 1.2×	56 0.9×	64 1.6×	42 1.2×	14	322
Laura Ghisolfi United States	7	219 1.0×	163 1.2×	115 1.8×	16 0.4×	37 1.0×	10	356
Berthold Gierke Germany	8	148 0.7×	105 0.8×	72 1.1×	18 0.5×	32 0.9×	12	277
He Hu China	10	165 0.8×	132 1.0×	104 1.6×	21 0.5×	56 1.6×	18	342
Jang-Hyun Choi South Korea	7	195 0.9×	139 1.1×	91 1.4×	15 0.4×	47 1.3×	9	334
Meghan M. Morrison United States	7	185 0.9×	171 1.3×	69 1.1×	48 1.2×	36 1.0×	8	380
Choong-Jae Lee South Korea	7	198 0.9×	144 1.1×	95 1.5×	15 0.4×	50 1.4×	7	335
Qianggang Dong China	10	203 1.0×	161 1.2×	113 1.8×	16 0.4×	57 1.6×	24	342
Atrayee Bhattacharya United States	13	310 1.5×	159 1.2×	98 1.5×	19 0.5×	91 2.5×	33	444

Countries citing papers authored by Heidi M. Haikala

Since Specialization

Citations

This map shows the geographic impact of Heidi M. Haikala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi M. Haikala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi M. Haikala more than expected).

Fields of papers citing papers by Heidi M. Haikala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi M. Haikala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi M. Haikala. The network helps show where Heidi M. Haikala may publish in the future.

Co-authorship network of co-authors of Heidi M. Haikala

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi M. Haikala. A scholar is included among the top collaborators of Heidi M. Haikala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi M. Haikala. Heidi M. Haikala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ilonen, Ilkka, et al.. (2025). Shaping the battlefield: EGFR and KRAS tumor mutations’ role on the immune microenvironment and immunotherapy responses in lung cancer. Cancer and Metastasis Reviews. 44(3). 56–56. 4 indexed citations

Klievink, Jay, Hanna Lähteenmäki, Emmi Jokinen, et al.. (2024). Bone Marrow Stromal Cells Hamper Leukemia Cell Induced NK Cell Activation and Cytotoxicity. Blood. 144(Supplement 1). 4814–4814. 2 indexed citations

Wang, Zhijia, et al.. (2023). Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release. Nucleic Acids Research. 51(20). 10970–10991. 2 indexed citations

Murumägi, Astrid, Teijo Pellinen, Mariliina Arjama, et al.. (2023). Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing. Lung Cancer. 178. 213–219.

Haikala, Heidi M. & Pasi A. Jänne. (2021). Thirty Years of HER3: From Basic Biology to Therapeutic Interventions. Clinical Cancer Research. 27(13). 3528–3539. 66 indexed citations

Pietilä, Mika, Johanna Lilja, Heidi M. Haikala, et al.. (2021). Sortilin‐related receptor is a druggable therapeutic target in breast cancer. Molecular Oncology. 16(1). 116–129. 6 indexed citations

Liu, Ying, Maria Llamazares Prada, Abhishekh Gupta, et al.. (2020). UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis. Cancer Research. 80(7). 1414–1427. 31 indexed citations

Haikala, Heidi M., Jens Köhler, Man Xu, et al.. (2020). Abstract 5192: EGFR inhibition enhances the cellular uptake and antitumor activity of the novel HER3 antibody drug conjugate U3-1402. Cancer Research. 80(16_Supplement). 5192–5192. 4 indexed citations

Paranal, Raymond M., Michael J. Poitras, Man Xu, et al.. (2019). Abstract 1732: Switch to MET oncogene dependence as a novel mechanism of drug resistance in EGFR-mutant lung cancer. Cancer Research. 79(13_Supplement). 1732–1732. 2 indexed citations

10.

Haikala, Heidi M., Elsa Marques, Mette Ilander, et al.. (2019). Abstract LB-189: Pharmacological reactivation of MYC-dependent apoptosis cooperates with anti-PD1 immunotherapy. Immunology. LB–189. 1 indexed citations

11.

Haikala, Heidi M., et al.. (2017). MYC and AMPK–Save Energy or Die!. Frontiers in Cell and Developmental Biology. 5. 38–38. 22 indexed citations

12.

Haikala, Heidi M., Juha Klefström, Martin Eilers, & Katrin E. Wiese. (2016). MYC-induced apoptosis in mammary epithelial cells is associated with repression of lineage-specific gene signatures. Cell Cycle. 15(3). 316–323. 3 indexed citations

13.

Haikala, Heidi M., et al.. (2016). Myc requires RhoA/SRF to reprogram glutamine metabolism. Small GTPases. 9(3). 274–282. 18 indexed citations

14.

Wiese, Katrin E., Heidi M. Haikala, Björn von Eyß, et al.. (2015). Repression of SRF target genes is critical for M yc‐dependent apoptosis of epithelial cells. The EMBO Journal. 34(11). 1554–1571. 28 indexed citations

15.

Nieminen, Anni I., Heidi M. Haikala, Topi A. Tervonen, et al.. (2013). Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis. Proceedings of the National Academy of Sciences. 110(20). E1839–48. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact